SCRS comments on the Federal Drug Administration (FDA) 2023 Draft Guidance: “Decentralized Clinical Trials for Drugs, Biological Products, and Devices Guidance for Industry, Investigators, and Other […]
Modern medicine owes a lot to clinical trial participants. Patients give their time, energy, and often literal blood and other specimens to help find cures for […]
There is a lot of discussion about diversity in clinical trials. The “why” is clear – more representation is needed to assess the effects of treatment […]
Clinical research is constantly evolving and advancing, and leveraging eClinical technologies such as electronic informed consent (eConsent), electronic Clinical Outcome Assessments (eCOA), medication adherence, televisits, geofencing, […]
In a world being increasingly driven by data, it is surprising to hear in casual conversations with other research professionals that most enrollment feasibility analyses are […]
Technology today can provide benefits and opportunities for clinical trial participants and sites alike, improving efficiency, accuracy, and engagement. Experts across the industry agree that for […]
How Co-Creation with DCT Vendors, Sponsors, and Sites Makes Participation in Decentralized Clinical Trials Easier For Sites Full-service decentralized clinical trial vendors can offer sponsors virtual […]
Every industry relies on technology for progress, but in the life science ecosystem, it truly impacts the work we do. Of course, technology often also comes […]